Technical Reports:

Report of the State of Texas US&R Task Force Readiness Evaluation Phase II Submitted to the Federal Emergency Management Agency for Presentation to the United States Congress, College Station, March 2000.

Report of the Miami Valley US&R Task Force Readiness Evaluation Phase II Submitted to the Federal Emergency Management Agency, Dayton, January 2000.

Full Papers:

C.S.N. Chujor, W.M. Holleran, K.R. Feingold, and P.M. Elias. (1998). Glucosylceramide synthase activity in murine epidermis: Quantitation, localization, regulation, requirement for barrier homeostasis. J. Lipid Res. 39, 277-285.

C.S.N. Chujor, F. Hammerschmid, and C. Lam. (1998). Cyclic nucleotide phosphodiesterase 4 isotypes are differentially expressed by primary keratinocytes and human epidermoid cell lines. J. Invest. Dermatol. 110, 287-291.

C.S.N. Chujor and F. Kricek. (1998). Expression Profile of NKG5, a gene identified in a subtractive human Natural Killer cell cDNA library. Eur. J. Immunogenetics.

C.S.N. Chujor, W.M. Holleran, P.M. Elias, and K.R. Feingold. (1998). Glucosylceramide synthase activity decreases with aging and in advanced- versus early-passage keratinocytes.

C.S.N. Chujor, A. Farrell, W.M. Holleran, K.R. Feingold, and P.M. Elias. (1998). Advanced-passage human keratinocytes display lipid metabolic abnormalities which mirror those in aged epidermis.

C.S.N. Chujor, L. Klein, and C. Lam. (1996). Selective inhibition of interleukin-Ib gene expression in activated RAW 264.7 macrophages by interferon-gamma. Eur. J. Immunol. 26, 1253-1259.

J.P. Houchins, F. Kricek, C.S.N. Chujor, C. Heise, T. Yabe, C. McSherry, and F.H. Bach. (1993). Genomic structure of NKG5, a human NK and T cell-specific activation gene. Immunogenetics 37, 102-107.

C.S.N. Chujor, B. Kuhn, B. Schwerer, H. Bemheimer, W.R. Levis and D. Bevec. (1992). Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial Lipoarabinomannan antigen. Clin. Exp. Immunol. 87, 398-403.

C.S.N. Chujor, H. Bernheimer, H. Regele, H.C. Meeker, W.R. Levis and B. Schwerer. (1991). Serum antibodies against peripheral nervous system antigens in leprosy. Int. J. Lepr. 59, 590-597.

C.S.N. Chujor, H. Bernheimer, W.R. Levis, and B. Schwerer. (1991). Serum IgA, and IgM antibodies against Mycobacterium leprae-derived Phenolic Glycolipid 1: A comparative study in leprosy patients and their contacts. Int. J. Lepr. 59, 441-449.

C.S.N. Chujor. (1990). Characterization of humoral immune responses in leprosy: Serum antibodies against phenolic glycolipid I and peripheral nervous system antigens (Ph.D. Thesis to University of Vienna, Vienna, Austria).

Beatrix Schwerer, C.S.N. Chujor, H. Bernheimer, J. Radl, J.J. Haaijman, H.C. Meeker, G. Sersen and W.R. Levis. (1989). IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: Subclass distribution and  relation to disease activity. Clin. Immunol. Immunopathol. 53, 202-211.

J.O. Folayan, F.O.B. Akojie and C.S.N. Chujor. Purification and characterization of polynucleotide-induced fibroblast Interferon (IFN-b) from fruit bats (Eidolon Helvum). Kenyan J. Sci. Technol. (B).

C.S.N. Chujor. (1985). Induction of Interferon by polyA:polyU in primary tissue cultures. (M.Sc. Thesis to University of Ife, Nigeria).

Abstracts and Conference Reports:

C.S.N. Chujor, T. Seki, K.R. Feingold, P.M. Elias, and W.M. Holleran. (1998). Glucosylceramide formation is critical for epidermal permeability barrier homeostasis. International Investigative Dermatology 1998, Cologne, Germany, 7-10 May, 1998. J. Invest. Dermatol. 110, 506.

C. Lam, C.S.N. Chujor, E. Schwarzinger, V.B. Morhenn, and A. Rot. (1998).    Co-localization of inducible nitric oxide synthase and nitration of tyrosine residues in psoriatic skin. International Investigative Dermatology 1998, Cologne, Germany, 7-10 May, 1998. J. Invest. Dermatol. 110, 634.

C.S.N. Chujor, W.M. Holleran, K.R. Feingold, and P.M. Elias. (1997). Glucosylceramide synthase activity levels change with epidermal differentiation, but not with acute barrier disruption. 58th Annual Meeting of the Society for Investigative Dermatology, Washington, D.C., 23-27 April, 1997. J. Invest. Dermatol. 108, 554.

C.S.N. Chujor, L. Klein, and C. Lam. (1997). Expression of cyclic AMP phosphodiesterase IV isogenes by human epidermal keratinocytes. 58th Annual Meeting of the Society for Investigative Dermatology, Washington, D.C., 23-27 April, 1997. J. Invest. Dermatol. 108, 603.

C.S.N. Chujor, L. Klein, and C. Lam. (1996). Selective inhibition of interleukin-lb gene expression in activated RAW 264.7 macrophages by interferon-gamma. 12th Annual Meeting of the Skin Pharmacology Society, Vienna, Austria, 2-5 November, 1995. Skin Pharmacol. 9, 145-146.

C.S.N. Chujor, L. Klein, and C. Lam. (1996). Modulation of pro-inflammatory mediator production by PDE type IV inhibitors. 12th Annual Meeting of the Skin Pharmacology Society, Vienna, Austria, 2-5 November, 1995. Skin Pharmacol. 9, 145.

C.S.N. Chujor, L. Klein, F. Hammerschmid, and C. Lam. (1995). Regulation and expression of inducible nitric oxide synthase gene in human epidermal keratinocytes. Fourth International Meeting of the Biology of nitric oxide. The Ritz-Carlton, Amelia Island, Florida, 17-21 September. Endothelium 3 Suppl., s20.

C.S.N. Chujor, J.P. Houchins, F.H. Bach, J.M. Seifert, and F. Kricek. (1992). NKG5, a cDNA isolated from natural killer Cells: analysis of the genomic DNA sequence and determination of the expression profile in various cell types. 8th International Congress of Immunology, Budapest, Hungary, 23-28 August.

C.S.N. Chujor, B. Kuhn, B. Schwerer, H. Bernheimer, W.R. Levis and D. Bevec (1991). Effect of Mycobacterial Lipoarabinomannan (LAM) antigen on mRNA accumulation for cytokines in Jurkat T cell and human Mono-Mac-6 cell lines. Jahrestagung der oesterreichischen Gesellschaft fuer Allergologie und Immunologie (OGAI), Vienna, Austria, 21-23 November.

C.S.N. Chujor, J.P. Houchins, F.H. Bach, J.M. Seifert, and F. Kricek. (1991). Genomic structure of NKG5, a gene specifically expressed in human T cells and NK cells. Jahrestagung der oesterreichischen Gesellschaft fuer Allergologie und Immunologie (OGAI), Vienna, Austria, 21-23 November.

C.S.N. Chujor, H. Bernheimer, W.R. Levis and B. Schwerer. (1990). Serum anti-nerve antibodies in Hansen's disease: Lack of evidence for their direct involvement in the pathogenesis of nerve damage. XIIIth Meeting of Swiss Neuropathologists with International Participation, St. Moritz, Switzerland, 24th-27th March.

C.S.N. Chujor, B. Schwerer, H. Bernheimer, and W.R. Levis. (1989). Humoral immune response to M.leprae-specific phenolic glycolipid 1: IgA subclass and possible serodiagnostic potential in leprosy, 7th International Congress of Immunology, West Berlin, F.R.G., July 30-August 5.

C.S.N. Chujor, B. Schwerer, H. Bernheimer, and W.R. Levis. (1989). Antibodies against M.leprae-specific phenolic glycolipid I and their relationship to leprosy disease activity. Jahrestagung der oesterreichischen Gesellschaft fuer Allergologie und Immunologie (OGAI), Vienna, Austria, 23-25 November.

C.S.N. Chujor, B. Schwerer, H. Bernheimer, J. Radl, J.J. Haaijman and W.R. Levis. (1989). Comparative studies of serum IgA1, IgA2 and IgM against phenolic glycolipid I in leprosy patients and contacts. 13th International Leprosy Congress '88, The Hague, The Netherlands, 11-17 September. Int. J. Lepr. 57 Suppl. 1, 304.

C.S.N. Chujor, B. Schwerer, H. Bernheimer, and W.R. Levis. (1988). Investigation of serum IgA against Mycobacterium leprae-derived phenolic glycolipid I and a semi-synthetic glyco-conjugate (D-BSA) in Hansen's disease. Jahrestagung der oesterreichischen Gesellschaft fuer Allergologie und Immunologie (OGAI), Vienna, Austria, 24-26 November.

B. Schwerer, C.S.N. Chujor, H. Bernheimer, J. Radl, J.J. Haaijman and W.R. Levis. (1988). Serum IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy patients and contacts. XIIth Meeting of Swiss Neuropathologists with International Participation, St. Moritz, Switzerland, 26th -29th March. Archives Suisses de Neurologie et de Psychiatrie 139, 74.

C.S.N. Chujor, B. Schwerer, H. Bernheimer, J. Radl, J.J. Haaijman and W.R. Levis. (1987). IgA-Antikorper gegen phenolisches Glykolipid I aus M. leprae im Serum von Leprapatienten und Kontaktpersonen. Gemeinsame Jahrestagung der oesterreichishen biochemischen Gesellschaft (OBG) und der oesterreichischen Gesellschaft fuer Allergologie und Immunologie (OGAI), Graz, Austria, 23-26 September.

Folayan, J.O., Akojie, F.O.B. & Chujor, C.S N. (1985) Investigation on the Antisickling effects of interferon from fruit bat (Eidolon helvum, Kerr). 13th International Congress of Biochemistry. Amsterdam, Netherlands. August 1985. pp. 25 - 30.

Folayan, J.O., Akojie, F.O.B. & Chujor, C.S.N. (1984) Interferon from fruit bat (Eidolon helvum, Kerr) tissue culture. 16th meeting of the Federation of European Biochemical Societies, June 1984. Moscow, USSR. pp. 464 of Abstract Book # XXII - 150.